Chefaa operates a patient‑focused pharmacy benefits platform that simplifies ordering, scheduling, and refilling recurring insured and non‑insured prescriptions for users and stakeholders in the healthcare chain. The company was founded in 2017 by Drs. Doaa Aref and Rasha Rady and is led by CEO Doaa Aref. Chefaa currently links over one million active users each month to more than 1,100 pharmacies across Saudi Arabia and Egypt. It is operational in eight Saudi cities following a successful launch there and is pursuing faster regional growth. The recent $5.25 million funding is intended to propel expansion and accelerate growth in Saudi Arabia. Management emphasizes designing new services and measuring Chefaa’s impact as it scales. Chefaa is an Egyptian on-demand medicine delivery platform that allows patients to order prescriptions and other products from pharmacies. The company was founded in 2017 by Dr Rasha Rady and Doaa Aref. It has launched a white-label product and plans to use new funding to grow its operations team and to launch a B2B service serving SMEs. The recently announced round was described only as a seven-figure dollar investment; the exact amount was not disclosed. Earlier funding includes investments announced in August last year from 500 Startups and Flat6Labs, and Crunchbase records $304,000 raised across two prior rounds. Vision Ventures said the investment will help expand services to improve availability of basic medicines and personal care products in the region.

Total raised

$5M

Funding rounds

2

Latest round

Equity

Latest activity

Dec 2023